# Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

> **NCT02767310** · PHASE1 · COMPLETED · sponsor: **Verisfield UK Ltd. Greek Branch** · enrollment: 49 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosuvastatin 20 mg film-coated tablets
- **DRUG:** Crestor 20 mg film-coated tablets

## Key facts

- **NCT ID:** NCT02767310
- **Lead sponsor:** Verisfield UK Ltd. Greek Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767310, "Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02767310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*